CINECA IRIS Institutional Research Information System

TADDEI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.571
EU - Europa 12.542
AS - Asia 8.866
SA - Sud America 1.300
AF - Africa 415
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 11
Totale 54.743
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.781
IT - Italia 4.744
CN - Cina 3.551
SG - Singapore 2.533
SE - Svezia 1.960
DE - Germania 1.234
BR - Brasile 1.202
BG - Bulgaria 1.201
HK - Hong Kong 1.113
CA - Canada 737
TR - Turchia 734
GB - Regno Unito 659
RU - Federazione Russa 561
UA - Ucraina 541
FI - Finlandia 539
VN - Vietnam 480
FR - Francia 256
CH - Svizzera 226
CI - Costa d'Avorio 201
IN - India 177
SM - San Marino 140
AT - Austria 113
BE - Belgio 98
SN - Senegal 67
NL - Olanda 55
ES - Italia 37
BJ - Benin 36
CZ - Repubblica Ceca 33
MX - Messico 31
AR - Argentina 30
BD - Bangladesh 29
IQ - Iraq 29
AU - Australia 28
ZA - Sudafrica 28
NG - Nigeria 23
PL - Polonia 22
PK - Pakistan 21
ID - Indonesia 18
JP - Giappone 18
MA - Marocco 17
UZ - Uzbekistan 17
IE - Irlanda 15
RO - Romania 15
CO - Colombia 14
KR - Corea 14
EC - Ecuador 13
LT - Lituania 13
VE - Venezuela 13
HR - Croazia 12
KZ - Kazakistan 12
EU - Europa 10
GR - Grecia 10
HU - Ungheria 10
IL - Israele 10
IR - Iran 10
KE - Kenya 10
NZ - Nuova Zelanda 10
CL - Cile 8
EG - Egitto 8
JM - Giamaica 8
NP - Nepal 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
JO - Giordania 7
KG - Kirghizistan 7
LU - Lussemburgo 7
PE - Perù 7
AZ - Azerbaigian 6
PT - Portogallo 6
PY - Paraguay 6
TH - Thailandia 6
TN - Tunisia 6
AL - Albania 5
BN - Brunei Darussalam 5
LB - Libano 5
MY - Malesia 5
OM - Oman 5
SA - Arabia Saudita 5
UY - Uruguay 5
BH - Bahrain 4
BY - Bielorussia 4
CY - Cipro 4
GH - Ghana 4
LV - Lettonia 4
MK - Macedonia 4
NO - Norvegia 4
PH - Filippine 4
PS - Palestinian Territory 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
LK - Sri Lanka 3
SV - El Salvador 3
TW - Taiwan 3
AM - Armenia 2
BO - Bolivia 2
DK - Danimarca 2
GE - Georgia 2
Totale 54.720
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.299
Ann Arbor 3.281
Fairfield 3.061
Ashburn 2.772
Houston 2.769
Chandler 1.892
Santa Clara 1.634
Singapore 1.213
Sofia 1.197
Seattle 1.172
Serra 1.099
Hong Kong 1.089
Shanghai 1.066
Wilmington 1.043
Cambridge 1.030
Milan 920
Beijing 777
New York 715
Jacksonville 707
Ottawa 684
Boardman 547
Princeton 525
Lawrence 483
Izmir 470
Medford 428
Nanjing 403
Des Moines 307
Munich 232
Istanbul 223
Abidjan 201
Dearborn 201
Dong Ket 197
Lancaster 196
Florence 187
Nanchang 186
Bern 184
Rome 183
Pisa 179
San Diego 157
Frankfurt am Main 139
The Dalles 132
Boulder 130
Falls Church 115
Kunming 113
London 113
Jüchen 109
Helsinki 103
Hefei 102
Vienna 98
Council Bluffs 96
Ogden 89
Brussels 85
Paris 85
Redwood City 81
Shenyang 79
São Paulo 74
Los Angeles 71
Dakar 67
Norwalk 65
Changsha 63
Hebei 62
Pune 59
Tianjin 58
Fuzhou 53
Belo Horizonte 52
Jiaxing 51
Washington 45
Rio de Janeiro 39
Cotonou 36
Padova 36
Naples 35
Auburn Hills 33
Dallas 33
Hangzhou 32
Jinan 32
Guangzhou 31
Nuremberg 30
Lucca 29
Nürnberg 29
Düsseldorf 28
Orange 27
Bologna 26
Turin 26
Marseille 25
Detroit 24
Palermo 24
Bremen 23
Changchun 23
Livorno 23
Phoenix 23
Quanzhou 23
Brasília 22
Chengdu 22
Verona 22
Zhengzhou 21
Lagos 20
Curitiba 19
Parma 19
Toronto 19
Warsaw 19
Totale 41.171
Salva come PNG Salva come JPEG
Nome #
Calcolo dell’Età Vascolare: un nuovo e concreto target terapeutico 1.540
Prognostic Value Of 24-hour Ambulatory Blood Pressure And Heart Rate Patterns In Diabetes: A 20-year Longitudinal Analysis Of The Chronic Diabetes Complications And All-cause Mortality In Pisa From 1999 Onwards (CHAMP1ON) Study Cohort 348
Association Between Blood Pressure Variability, Cardiovascular Disease And Mortality In Type 2 Diabetes: A Systematic Review And Meta-Analysis 308
Identification of a cytochrome P450-2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients 298
Randomized trial on the effects of a combined physical/cognitive training in aged MCI subjects: the Train the Brain study 261
Habitual physical activity and arterial stiffness in normotensive and hypertensive subjects 247
Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes 210
Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors 201
Potassium-rich and sodium-poor salt reduces blood pressure in hospitalized patients. 196
Maximal postischemic forearm vasodilation in human hypertension: a reassessment of the method 193
Vascular Function Is Improved After an Environmental Enrichment Program: The Train the Brain-Mind the Vessel Study 193
Active and inactive renin in human forearm of hypertensive patients. 188
INCREASED CENTRAL PRESSURE AUGMENTATION IS ASSOCIATED WITH REDUCED SLEEP DURATION IN INDIVIDUALS EXPOSED TO AIRCRAFT NOISE POLLUTION: THE SERA-CV STUDY 188
Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. 184
Endothelial dysfunction in hypertension: Pathophysiological mechanism or marker of cardiovascular risk? 183
Renal changes induced by nitric oxide and prostaglandin synthesis reduction: effects of trandolapril and verapamil. 182
Cigarette Smoking and Hypertension 182
Endothelial Function and Renal Vasodilation, But not Arterial Stiffness, are Impaired in Lean, Normotensive Patients with Sleep-Apnea Syndrome 180
Neuroendocrine Dysregulation in Irritable Bowel Syndrome Patients: A Pilot Study 180
Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome 177
Sporadic or familial head neck paragangliomas enrolled in a single center: Clinical presentation and genotype/phenotype correlations 176
Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. 175
Vascular renin-angiotensin system and neurotransmission in hypertensive persons. 171
Recombinant human TSH reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma 170
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 168
Functional and structural alterations of large arteries: methodological issues. 168
ROLE OF ENDOTHELIAL NO IN THE VASORELAXING EFFECTS INDUCED BY H2S IN CONDUCTANCE AND RESISTANCE RAT ARTERIES 168
Angiotensin receptor blockers: Therapeutic targets and cardiovascular protection 167
Adipocytokine levels mark endothelial function in normotensive individuals 167
“Cardiovascular parameters changes in patients with erectile dysfunction using 5-PDE inhibitors: a first study with Sildenafil 50 mg and Vardenafil 10 mg.” 166
Birth weight and arterial hypertension 165
Oxidative stress, chronic inflammation, and telomere length in patients with periodontitis 163
Obesity in the childhood: a link to adult hypertension 163
Anthropometric and dietary determinants of blood pressure in over 7000 Mediterranean women: the European Prospective Investigation into Cancer and Nutrition-Florence cohort 161
Phosphodiesterase 5 inhibition to treat essential hypertension: is this the beginning of the story? 160
Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. 159
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women 158
Device-based therapies for resistant hypertension. 158
The effects of diuretic and beta-blocker treatment on cardiac and vascular structural changes in untreated essential hypertensive patients. 157
Adenosine causes the release of active renin and angiotensin II in the coronary circulation of patients with essential hypertension 157
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 155
Pathogenetic factors in hypertension. Endothelial factors. 154
At the beginning of stiffening: endothelial dysfunction meets "pulsology" 154
Hypertension in special populations: athletes. 154
Adenosine causes angiotensin II release in human forearm arterioles. 154
Endothelium-dependent contractions to endothelin in the rat aorta are mediated by thromboxane A2. 152
Acute pressure overload induces oxidative stress and tPA expression in rat mesenteric small arteries 152
Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension 152
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 151
Multiparametric evaluation of vascular function in lean, normotensive patients with obstructive sleep apnoea 150
Third molar surgical removal: a possible model of human systemic inflammation? A preliminary investigation 149
null 149
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers 149
Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. 148
Adenosine and the vascular tissue renin-angiotensin system in the forearm of essential hypertensive patients 147
Menopause is associated with endothelial dysfunction in women 147
Adenosine activates a vascular renin-angiotensin system in hypertensive subjects. 147
Endothelium-dependent vasodilation in hypertensive patients 146
A renin-secreting tumor 146
The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients 146
Interactions between sympathetic nervous system and endogenous endothelin in patients with essential hypertension. 145
Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: A pilot study 145
Hypertension causes premature aging of endothelial function in humans 145
Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension 144
Angiotensin-converting enzyme inhibitors in hypertension: a review. Int 143
Calcium entry blockade and selective alpha-adrenergic stimulation in animals and humans 143
Vascular tissue renin-angiotensin system in hypertensive humans. 143
Different Impact of Essential Hypertension on Structural and Functional Age-Related Vascular Changes 143
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke 141
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 141
Angiotensin II and sympathetic activity in sodium-restricted essential hypertension. 141
Lack of evidence for Na/K ATPase inhibitor as a cause of low renin human hypertension. 140
Insulin sensitivity, vascular reactivity, and clamp-induced vasodilatation in essential hypertension 140
Inhibitors of angiotensin-converting enzyme in the treatment of arterial hypertension. 139
Chronic Treatment With Long-Acting Nifedipine Reduces Vasoconstriction to Endothelin-1 in Essential Hypertension. Hypertension 139
Blood pressure through aging and menopause 139
Renal Resistive Index Predicts Post–Bariatric Surgery Renal Outcome in Nondiabetic Individuals with Severe Obesity 139
Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension 139
The assessment of endothelial function: from research into clinical practice. 139
Endothelial dysfunction in hypertension. 138
Evolving the concept of regulation of vascular tone in humans. 138
VASORELAXING EFFECTS OF H2S IN RAT MESENTERIC ARTERIES 137
Early impairment of coronary flow reserve and increase in minimum coronary resistance in borderline hypertensive patients 137
Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus 137
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 137
Correlation between Vascular Age and surrogate markers of atherosclerosis and vascular aging 137
null 136
Hypertension, left ventricular hypertrophy and chronic kidney disease 136
Antihypertensive drugs and reversing of endothelial dysfunction in hypertension 136
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH) 135
The authors' reply. 135
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 135
Cutaneous vasodilation to acetylcholine in patients with essential hypertension 135
Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients 135
Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients. 135
1140-1147 Association between short leukocyte telomere length, endotoxemia, and severe periodontitis in people with diabetes: A cross-sectional survey 135
Systemic Inflammation after Third Molar Removal: A Case-Control Study 135
Prognostic value of flow mediated dilation in patients with systemic lupus erythematosus: A pilot prospective cohort study. 135
Narrare la malattia per costruire la salute. Una prospettiva multidisciplinare 135
Dipyridamole decreases circulating renin-angiotensin system activity in hypertensive patients. 134
Totale 17.479
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.949
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020762 0 0 0 0 0 0 0 0 0 0 619 143
2020/20213.443 292 177 222 161 364 149 283 353 338 307 210 587
2021/20225.466 138 334 106 380 1.029 726 162 324 259 204 321 1.483
2022/20236.008 777 671 360 518 610 819 84 463 1.055 79 430 142
2023/20244.874 543 491 568 363 692 832 187 188 141 111 206 552
2024/202511.970 169 637 272 853 1.339 1.699 1.386 1.003 1.639 2.152 821 0
Totale 55.479